fluorodeoxyglucose f18 has been researched along with Amyloidosis in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (10.94) | 29.6817 |
2010's | 35 (54.69) | 24.3611 |
2020's | 22 (34.38) | 2.80 |
Authors | Studies |
---|---|
Arias, JF; Benedet, A; Bezgin, G; Bunai, T; Kang, MS; Lussier, F; Matsudaira, T; Obi, T; Ottoy, J; Ouchi, Y; Pascoal, TA; Poltronetti, NM; Rosa-Neto, P; Savard, M; Terada, T; Therriault, J; Tissot, C; Tsukada, H; Wang, YT | 1 |
Kang, BS; Kim, M; Lee, YJ; Park, SH; Seo, M | 1 |
Cui, R; Ding, J; Huo, L; Luo, Y | 1 |
Jang, H; Kim, HJ; Kim, S; Kim, SJ; Kim, YJ; Na, DL; Seo, SW; Woo, SY | 1 |
Appollonio, I; Crivellaro, C; Ferrarese, C; Ferri, F; Formenti, A; Gallivanone, F; Guerra, L; Isella, V; Mapelli, C; Morzenti, S; Musarra, M; Pacella, S | 1 |
Bengel, FM; Diekmann, J | 1 |
Bischof, GN; Bohn, KP; Doering, E; Drzezga, A; Ellingsen, LM; Hoenig, MC; van Eimeren, T | 1 |
Crowson, CS; Davis Iii, JM; Duong, SQ; Jones, DT; Mielke, MM; Myasoedova, E; Nguyen, A; Vassilaki, M; Vemuri, P | 1 |
Hu, Y; Ning, Y; Shi, X; Sun, B; Wu, Y; Zhou, N | 1 |
Cao, X; Li, J; Luo, Y; Pan, Q | 1 |
Hatipoglu, S; Wechalekar, AD; Wechalekar, K | 1 |
Castilloveitia, GL; Di Carli, MF; Dorbala, S; El-Sady, MS; Falk, RH; Kijewski, MF; Nodoushani, A; Park, MA | 1 |
Prato, FS; Wisenberg, G | 1 |
Albano, D; Bertagna, F; Bertoli, M; Cerudelli, E; Durmo, R; Gazzilli, M; Giubbini, R | 1 |
Adhikari, N; de Idiaquez Bakula, DA; Singhal, A; Sotoudeh, H | 1 |
Alcolea, D; Altuna, M; Annus, T; Barroeta, I; Belbin, O; Benejam, B; Blesa, R; Camacho, V; Carmona-Iragui, M; Clarimón, J; Estellés, T; Fernández, S; Fortea, J; Giménez, S; González-Ortiz, S; Holland, AJ; Illán-Gala, I; Lehmann, S; Lleó, A; Montal, V; Muñoz, L; Osorio, RS; Pegueroles, J; Valldeneu, S; Videla, L; Videla, S; Vilaplana, E; Wilson, LR; Zaman, SH | 1 |
Bharadwaj, M; Mittal, A; Prakash, S; Pramanik, R; Shamim, SA; Tripathy, S | 1 |
Kim, SH; Kim, SJ; Kim, YS | 1 |
Byun, MS; Jeon, SY; Kang, KM; Kim, JW; Kim, YK; Lee, DY; Lee, JH; Lee, JY; Shin, SA; Sohn, BK; Sohn, CH; Yi, D | 1 |
Boenink, M; Isaacs, JD | 1 |
Song, T; Sun, J; Wang, J; Zhao, B | 1 |
Bouckaert, F; De Winter, FL; Dupont, P; Emsell, L; Koole, M; Sunaert, S; Takamiya, A; Van den Stock, J; Van Laere, K; Vande Casteele, T; Vandenberghe, R; Vandenbulcke, M | 1 |
Prause, CA; Weindling, SM; Zhai, Q | 1 |
Boursot, C; Coindre, JP; Hachemi, M; Molfino, I; Piccoli, GB | 1 |
Aliaga, A; Cuello, AC; Dea, D; Do Carmo, S; Fonov, VS; Gauthier, S; Kang, MS; Kostikov, A; Mathieu, A; Parent, MJ; Poirier, J; Rosa-Neto, P; Shin, M; Soucy, JP; Zimmer, ER | 1 |
Buchert, R; Lange, C; Makowski, MR; Peters, O; Pietrzyk, U; Spies, L; Suppa, P | 1 |
Arnaldi, D; Bauckneht, M; Chincarini, A; Efeturk, H; Girtler, N; Grazzini, M; Massa, F; Morbelli, S; Nobili, F; Pagani, M; Pardini, M; Piva, R; Sambuceti, G | 1 |
Dong, A; Liang, X; Liu, Y; Ran, P; Zhang, Y | 1 |
Albert, NL; Bartenstein, P; Baumann, K; Blume, T; Brendel, M; Deussing, M; Focke, C; Gildehaus, FJ; Herms, J; Lindner, S; Ozmen, L; Peters, F; Rominger, A; von Ungern-Sternberg, B | 1 |
Boerboom, AL; Dierckx, RA; Glaudemans, AW; Hazenberg, BP; Noordzij, W; Slart, RH | 1 |
Dierckx, RA; Glaudemans, AW; Hazenberg, BP; Noordzij, W; Slart, RH | 1 |
Abdou, E; Amre, R; Derbekyan, V; Hickeson, M; Sebag, M | 1 |
Dhull, VS; Jain, S; Kumar, R; Mukherjee, A; Pal, L; Parida, GK; Sharma, P | 1 |
Baqir, M; Lowe, V; Ryu, JH; Yi, ES | 1 |
Cruz, J; Ferreira, L; Pacheco, C | 1 |
Gerbaudo, VH; Wachsmann, JW | 1 |
Kecler-Pietrzyk, A; Kok, HK; Lyburn, ID; Torreggiani, WC | 1 |
Barkhof, F; Caroli, A; Carter, SF; Choo, IH; Frisoni, GB; Nordberg, A; Ossenkoppele, R; Prestia, A; Scheltens, P; Schöll, M; Teunissen, CE; Van Berckel, B; van der Flier, WM; Wade, SK; Wall, A | 1 |
Anić, B; Barešić, M; Brčić, L; Hećimović, A; Janevski, Z; Sreter, KB | 1 |
Bottelbergs, A; Kelley, J; Langlois, X; Richardson, J; Schmidt, M; Staelens, S; Stroobants, S; Verhaeghe, J; Waldron, AM; Wyffels, L | 1 |
Broski, SM; Dispenzieri, A; Howe, BM; Johnson, GB; Spinner, RJ | 1 |
Boeve, BF; Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Lundt, ES; Machulda, MM; Mielke, MM; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
Koukalová, R; Řehák, Z; Stulík, J; Svobodová, I; Szturz, P | 1 |
Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Machulda, MM; Mielke, MM; Petersen, RC; Reyes, DA; Roberts, RO; Senjem, ML; Therneau, TM; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
Chen, Y; Shao, F; Wang, Y; Zhang, M; Zou, Y | 1 |
Borkar, S; Ghossein, RA; Schöder, H; Singh, B; Yoshida, A | 1 |
Chary-Valckenaere, I; Costantino, F; Dintinger, H; Loeuille, D; Péré, P | 1 |
Eguchi, K; Hayashida, T; Izumi, Y; Kawakami, A; Koga, T; Makiyama, J; Migita, K; Miyashita, T; Nishino, Y; Tamai, M | 1 |
Ahn, BC; Lee, J; Lee, SW; Seo, JH | 1 |
Guan, Y; Lin, X; Tan, H; Zhao, J | 1 |
Fain, O; Ghrenassia, E; Mekinian, A; Pop, G; Prendki, V; Roberts, S; Stirnemann, J; Weinmann, P | 1 |
Miao, F; Tang, YH; Wang, JC; Wu, YW; Zong, J | 1 |
Galas, JL; Neuman, A; Ouvrier, MJ; Pop, G; Soussan, M; Weinmann, P | 1 |
Koga, T; Maehara, Y; Maruyama, R; Shikada, Y; Yano, T; Yoshiya, S | 1 |
Ghobrial, I; Giardino, A; Howard, S; Jagannathan, J; Krajewski, K; O'Regan, K; Ramaiya, N; Zukotynski, K | 1 |
Berthier, S; Dhote, R; Fain, O; Federici, L; Jaccard, A; Launay, D; Lefèvre, G; Mekinian, A; Soussan, M; Valeyre, D | 1 |
Babiak, M; Caso, F; Comi, G; Filippi, M; Gesierich, B; Gorno-Tempini, ML; Henry, M; Huang, EJ; LaMarre, A; Magnani, G; Miller, BL; Rabinovici, GD; Seeley, WW; Sidhu, M | 1 |
Bimonte-Nelson, H; Braden, BB; Emerson Lombardo, N; Engler-Chiurazzi, E; Garcia, AN; Kusne, Y; LaFerla, F; Lue, L; Moses, GS; Tran, H; Valla, J; Walker, DG; Wolf, AB; Young, N | 1 |
Adriaanse, SF; Barkhof, F; Boellaard, R; Lammertsma, AA; Ossenkoppele, R; Scheltens, P; van Berckel, BN; van der Flier, WM; Windhorst, AD; Zwan, MD | 1 |
Alavi, A; Duarte, PS; Kung, J; Yu, JQ; Zhuang, H | 1 |
Knight, S; Ollenberger, GP; Tauro, AJ | 1 |
Cohen, M; Grubstein, A; Kramer, MR; Sapir, EE; Shitrit, D | 1 |
Ameshima, S; Demura, Y; Ishizaki, T; Itoh, H; Mizuno, S; Morikawa, M; Nakanishi, M; Sasaki, M; Takeda, N; Uesaka, D; Umeda, Y | 1 |
Fukae, J; Inoue, T; Inubushi, M; Itoh, T; Kanegae, K; Koike, T; Morita, K; Serizawa, I; Shiga, T; Tamaki, N | 1 |
5 review(s) available for fluorodeoxyglucose f18 and Amyloidosis
Article | Year |
---|---|
[Clinical use of Cardiac Nuclear Medicine in Germany].
Topics: Amyloidosis; Cardiomyopathies; Fluorodeoxyglucose F18; Germany; Glucose; Humans; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Tomography, Emission-Computed, Single-Photon | 2022 |
Diagnostic performance of PET for detection of cardiac amyloidosis: A systematic review and meta-analysis.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2020 |
Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart Diseases; Humans; Infections; Lung Diseases; Mediastinal Diseases; Multimodal Imaging; Myocardium; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Diseases; Thoracic Diseases; Thoracic Injuries; Thoracic Vertebrae; Thorax; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Multimodality imaging in amyloidosis.
Topics: Amyloidosis; Brain; Diagnostic Imaging; Echocardiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluoroscopy; Heart; Hematologic Neoplasms; Humans; Inflammation; Joints; Lung; Magnetic Resonance Imaging; Multimodal Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Viscera | 2012 |
18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
Topics: Aged; Aged, 80 and over; Amyloid; Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
1 trial(s) available for fluorodeoxyglucose f18 and Amyloidosis
Article | Year |
---|---|
Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloidogenic Proteins; Amyloidosis; Brain; Cognition; Depression; Depressive Disorder; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Late Onset Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Risk Factors | 2021 |
58 other study(ies) available for fluorodeoxyglucose f18 and Amyloidosis
Article | Year |
---|---|
Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloidosis; Aniline Compounds; Atrophy; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2022 |
Amyloid Arthropathy and Pseudomyopathy Associated With Multiple Myeloma Detected by 18F-Florapronol Amyloid PET/CT.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Humans; Joint Diseases; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
Secondary Gastrointestinal Amyloidosis With Increased 18 F-FDG Uptake as the Only Presentation in a Patient With Multiple Myeloma.
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Cognition; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloidosis; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Parietal Lobe; Positron-Emission Tomography | 2022 |
Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Apolipoprotein E4; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Gatekeeping; Humans; Positron-Emission Tomography; Reproducibility of Results | 2022 |
Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
Topics: Aged; Aging; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Arthritis, Rheumatoid; Biomarkers; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography | 2022 |
Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidogenic Proteins; Amyloidosis; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography | 2022 |
Myocardial Uptake of 68Ga-Pentixafor in a Patient With Systemic Amyloidosis.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
Extensive cardiac FDG uptake in a patient with AL amyloidosis.
Topics: Adult; Amyloidosis; Fluorodeoxyglucose F18; Heart; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Positron Emission Tomography Computed Tomography | 2023 |
Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using
Topics: Aged; Amyloidosis; Female; Finland; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Reproducibility of Results | 2021 |
Reproducibility and repeatability of assessment of myocardial light chain amyloidosis burden using
Topics: Aged; Amyloidosis; Female; Finland; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Reproducibility of Results | 2021 |
Cardiac amyloidosis incidentally detected by 18F-FDG PET/CT.
Topics: Amyloidosis; Contrast Media; Fluorodeoxyglucose F18; Heart; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Solitary Pulmonary Nodule | 2020 |
18F-FDG Uptake in a T2 Hypointense Paraspinal Mass.
Topics: Aged; Amyloidosis; Biological Transport; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Spine | 2020 |
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Down Syndrome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofilament Proteins; Positron-Emission Tomography; Prevalence; Spain; tau Proteins; United Kingdom | 2020 |
Isolated Lymph Node Amyloidosis: Response Assessment to Chemotherapy on Serial 18F-FDG PET/CT Scans.
Topics: Amyloidosis; Biopsy; Bortezomib; Cyclophosphamide; Dexamethasone; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2020 |
Serum albumin and beta-amyloid deposition in the human brain.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Serum Albumin | 2020 |
Biomarkers for dementia: too soon for routine clinical use.
Topics: Alzheimer Disease; Amyloidosis; Biomarkers; Dementia; Fluorodeoxyglucose F18; Humans | 2020 |
Lung cancer combined with diffuse peritoneal and mesenteric amyloidosis detected on 18F-FDG PET/CT: A case report.
Topics: Aged; Amyloidosis; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesentery; Omentum; Pneumonectomy; Positron Emission Tomography Computed Tomography | 2021 |
Pharyngeal amyloidomas: Variable appearance on imaging.
Topics: Amyloidosis; Biopsy; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Pharyngeal Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Doxycycline treatment in dialysis related amyloidosis: discrepancy between antalgic effect and inflammation, studied with FDG-positron emission tomography: a case report.
Topics: Amyloidosis; Anti-Bacterial Agents; Doxycycline; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Positron-Emission Tomography; Renal Dialysis; Treatment Outcome | 2017 |
Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Animals, Genetically Modified; Biomarkers; Brain; Brain Chemistry; Cognitive Dysfunction; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Male; Memory Disorders; Multimodal Imaging; Mutation; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography; Protein Aggregation, Pathological; Radiopharmaceuticals; Rats; Rats, Transgenic; Rats, Wistar | 2017 |
Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Survival Analysis; tau Proteins | 2018 |
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Brain; Cognitive Dysfunction; Cohort Studies; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography | 2018 |
FDG PET/CT in a Case of Dural Amyloidoma.
Topics: Amyloidosis; Dura Mater; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Calcium-Binding Proteins; Carbazoles; Disease Models, Animal; Fluorodeoxyglucose F18; Longitudinal Studies; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Microglia; Positron-Emission Tomography; Radiochemistry; Receptors, GABA | 2018 |
Fluorine-18 labeled fluorodeoxyglucose PET useful for therapy monitoring in localized AL amyloidosis?
Topics: Amyloidosis; Fluorodeoxyglucose F18; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2013 |
Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Amyloidosis in FDG-avid lymph nodes.
Topics: Amyloidosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Pulmonary amyloidosis in a patient with Langerhans cell histiocytosis: diagnostic dilemma on 18F-FDG PET/CT.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Lung Diseases; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
18F-FDG PET scanning in pulmonary amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Male; Middle Aged; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Function Tests; Risk Factors; Tomography, X-Ray Computed | 2014 |
Positive positron emission tomography/computed tomography scan and multiple pulmonary nodules: an unusual diagnosis.
Topics: Aged, 80 and over; Amyloidosis; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Dialysis related amyloid arthropathy on ¹⁸FDG PET-CT.
Topics: Amyloidosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Joint Diseases; Kidney Failure, Chronic; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Renal Dialysis; Shoulder Joint; Tomography, X-Ray Computed | 2014 |
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Atrophy; Biomarkers; Disease Progression; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; tau Proteins | 2015 |
Solitary pulmonary amyloidoma mimicking lung cancer on 18F-FDG PET-CT scan in systemic lupus erythematosus patient.
Topics: Amyloidosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Lupus Erythematosus, Systemic; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2015 |
Quantitative μPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloidosis; Animals; Biomarkers; Brain; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Immunohistochemistry; Male; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves.
Topics: Amyloid Neuropathies; Amyloidosis; Aniline Compounds; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Aniline Compounds; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Thiazoles | 2015 |
[Localized Amyloidosis Involving the Nasal Cavity].
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nasal Cavity; Nose Diseases; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloidosis; Aniline Compounds; Brain; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Thiazoles | 2017 |
Widespread Amyloidosis Around Major Joints on 18F-FDG PET/CT.
Topics: Amyloidosis; Ankle; Biopsy; Elbow; Female; Fluorodeoxyglucose F18; Groin; Hip; Humans; Knee; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Shoulder; Wrist | 2017 |
Incidental detection of concurrent extramedullary plasmacytoma and amyloidoma of the nasopharynx on [18F]fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Nasopharyngeal Neoplasms; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Fixed digital contractures revealing light-chain amyloidosis.
Topics: Aged; Amyloidosis; Contracture; Dyspnea; Female; Fluorodeoxyglucose F18; Hand Bones; Humans; Immunoglobulin kappa-Chains; Immunoglobulin Light Chains; Macroglossia; Radiography; Radioisotopes; Shoulder Joint | 2009 |
Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu's arteritis.
Topics: Amyloidosis; Aorta, Thoracic; Biomarkers; Disease Progression; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Positron-Emission Tomography; Prednisolone; Serum Amyloid A Protein; Takayasu Arteritis; Treatment Outcome; Young Adult | 2010 |
Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT.
Topics: Amyloidosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Findings of pulmonary amyloidosis on dual phase FDG PET/CT imaging.
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Visualization of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET/CT scan.
Topics: Amyloid; Amyloidosis; Arthrography; Fluorodeoxyglucose F18; Hand; Humans; Immunoglobulin Light Chains; Joints; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Imaging features of small intestinal amyloidosis: a case report.
Topics: Amyloidosis; Barium Sulfate; Contrast Media; Fluorodeoxyglucose F18; Humans; Intestinal Diseases; Intestine, Small; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Tracheobronchial FDG uptake in primary amyloidosis detected by PET/CT.
Topics: Aged; Amyloidosis; Biological Transport; Bronchi; Bronchography; Fluorodeoxyglucose F18; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Trachea | 2011 |
Localized pleural amyloidosis: report of a case.
Topics: Adult; Amyloidosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Pleural Diseases; Positron-Emission Tomography; Radiographic Image Enhancement; Radiography, Thoracic | 2012 |
Nonfluent/agrammatic PPA with in-vivo cortical amyloidosis and Pick's disease pathology.
Topics: Aged; Alzheimer Disease; Amyloidosis; Aniline Compounds; Carbon Radioisotopes; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Pick Disease of the Brain; Positron-Emission Tomography; Primary Progressive Nonfluent Aphasia; Thiazoles | 2013 |
Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention.
Topics: Alzheimer Disease; Amyloidosis; Animals; Cognition; Dietary Supplements; Electron Transport Complex IV; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mitochondrial Diseases; Nutritional Physiological Phenomena; Plant Extracts; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Sex Characteristics; Synaptophysin; tau Proteins | 2012 |
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Blood Glucose; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Severity of Illness Index; Thiazoles | 2013 |
Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography.
Topics: Aged; Amyloidosis; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Pneumonia; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
False-positive FDG positron emission tomography in pulmonary amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloidosis; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2004 |
Pulmonary amyloidosis: detection with PET-CT.
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
[FDG-PET findings of nodular pulmonary amyloidosis with a long-term observation].
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Diseases; Middle Aged; Positron-Emission Tomography | 2007 |
Lymphadenopathy due to amyloidosis secondary to Sjögren syndrome and systemic lupus erythematosus detected by F-18 FDG PET.
Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Lymphatic Diseases; Middle Aged; Positron-Emission Tomography; Sjogren's Syndrome | 2007 |